Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

LOR253 is an activator of the transcription factor Kruppel-like factor 4 (KLF4).1 It increases levels of KLF4 and induces apoptosis in HCC1187, HCC38, and MDA-MB-468 cancer cells when used at concentrations of 5 and 10 µM. It is cytotoxic in a panel of 16 acute myeloid leukemia (AML) and lymphoma cell lines (IC50s = 0.057-1.75 µM) and induces cell cycle arrest at the G0/G1 phase in MV4-11, KG-1, and EoL-1 cells.2 LOR253 (1 mg/kg) accelerates wound healing, as well as increases plasma levels of KLF4 and wound site myeloid-derived suppressor cell (MDSC) accumulation, in an ob/ob mouse model of diabetic wound healing.3
WARNING This product is not for human or veterinary use.
1. Krüppel-
2. APTO-
3. KLF4 promotes diabetic chronic wound healing by suppressing Th17 cell differentiation in an MDSC-